In addition, studies suggested that cells transformed from NSCLC to small cell lung cancer (SCLC) will be sensitivity to navitoclax, and down-regulation of EGFR and RB were biomarkers for this transform [11, 40]. Here, RB1 is linked to small cell lung carcinoma.